AstraZeneca PLC Nexium-Aspirin Combo Gets EU OK
Published: Aug 02, 2011
AstraZeneca's drug Axanum -- a combination of low-dose aspirin and the active ingredient in Nexium -- has won a positive agreement for approval in 23 European Union states and Norway. The medicine is designed for use by patients at high risk of heart attacks or strokes who are also at increased risk of stomach ulcers. Aspirin can provoke ulcers and gastrointestinal bleeding.